证券代码：002141 证券简称：贤丰控股 公告编号：2025-075 贤丰控股股份有限公司 拟签订《关于解除饲料购销协议及其补充协议的协议》和《关 于解除租赁合同的协议》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）的控股孙公司遵义市康禧元动 物营养科技有限公司（以下简称"康禧元"）前期与遵义日泉饲料生物科技有限 公司及其股东广东天农集团股份有限公司（原用名：广东天农食品集团股份有限 公司）签订了《饲料厂租赁合同》，并与贵州湄潭日泉农牧有限公司、贵州桐梓 日泉农牧有限公司、贵州日泉种猪育种有限公司签订了《饲料购销协议》及补充 协议。详见公司 2024 年 11 月 5 日披露于巨潮资讯网（www.cninfo.com.cn）上 的《关于签订<饲料厂租赁合同>和<饲料购销协议>的公告》（公告编号：2024-122）。 2025 年 9 月 26 日公司召开第八届董事会第二十一次会议审议通过了《拟签 订<关于解除饲料购销协议及其补充协议的协议>和<关于解除租赁合同的协议> 的议案》，基于公司业务发展情况，现经各方 ...

第八届董事会第二十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1. 贤丰控股股份有限公司（以下简称"公司"）第八届董事会第二十一次 会议通知已提前以电话、邮件等方式发出。 2. 会议于 2025 年 9 月 26 日在公司会议室以现场与电子通信（线上会议） 相结合的方式召开。 3. 会议应参与表决董事 7 人，实际参与表决董事 7 人（其中董事丁晨先生、 谢文彬先生、万荣杰先生和独立董事肖世练先生、梁融先生以线上会议方式出 席）。 4. 会议由公司董事长韩桃子女士主持。 证券代码：002141 证券简称：贤丰控股 公告编号：2025-073 贤丰控股股份有限公司 5. 本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 二、董事会会议审议情况 特此公告。 1. 审议通过《关于为控股子公司向银行借款事项提供担保和反担保的议案》 表决结果：以 7 票赞成、0 票反对、0 票弃权的表决结果，通过本议案。 2. 审议通过《拟签订<关于解除饲料购销协议及其补充协议的协议>和<关 于解除租 ...

Core Viewpoint - The company, Xianfeng Holdings, is planning to exit the feed business through the termination of existing agreements with its partners, indicating a strategic shift in its business operations [1] Group 1: Company Actions - Xianfeng Holdings' subsidiary, Zunyi Kangxiyuan Animal Nutrition Technology Co., Ltd., has signed a feed factory lease contract and feed purchase agreements with several companies [1] - The company’s board of directors has approved the proposal to terminate the feed purchase agreements and the lease contract, reflecting a decision based on the company's business development situation [1] - The termination agreements will be signed following friendly negotiations with the counterparties, and the company will gradually complete the handover of related matters after the agreements are finalized [1] Group 2: Future Implications - The exit from the feed business suggests a potential refocus on other areas of operation, which may impact the company's future strategic direction and resource allocation [1] - The authorization of the chairman or designated agent to sign the termination documents indicates a streamlined process for the transition away from the feed business [1]

Core Viewpoint - Xianfeng Holdings (stock code: 002141) has approved the proposal to terminate relevant agreements related to its subsidiary Kangxiyuan's feed business, indicating a strategic exit from this sector [1] Group 1: Agreement Termination - The board of Xianfeng Holdings convened on September 26, 2025, to review and approve the termination of agreements with Zunyi Riquan and other companies regarding the leasing and purchasing of feed factories [1] - Kangxiyuan plans to negotiate the termination of these agreements and exit the feed business, with the handover process to be completed gradually after the agreements are signed [1] Group 2: Financial Implications - The agreement regarding the termination of the feed purchase and sales agreements stipulates that all outstanding payments must be settled by October 15, 2025 [1] - The rental contract termination agreement specifies that the landlord must return 488,200 yuan in rent by October 15 [1] - The termination of these agreements is not expected to have a significant impact on the company's future operations [1]

Market Overview - On September 25, the animal health sector declined by 1.62% compared to the previous trading day, with the leading stock, Driveline, experiencing a drop of 4.04% [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Stock Performance - The following stocks in the animal health sector showed notable declines: - Driveline (Code: 838275) closed at 9.50, down 4.04% with a trading volume of 19,300 lots [1] - Shunlian Bio (Code: 688098) closed at 10.43, down 3.43% with a trading volume of 76,300 lots [1] - Yongshun Bio (Code: 839729) closed at 9.74, down 2.89% with a trading volume of 20,800 lots [1] - Other notable declines include *ST Green Health (Code: 002868) down 2.39% and Shoufeng Holdings (Code: 002141) down 2.33% [1] Capital Flow - The animal health sector saw a net outflow of 113 million yuan from institutional investors, while retail investors experienced a net inflow of 61.16 million yuan [1] - The following stocks had significant capital flow: - Zhongmu Co. (Code: 600195) had a net inflow of 986,800 yuan from institutional investors [2] - Pulaike (Code: 603566) saw a net inflow of 764,200 yuan from retail investors [2] - *ST Green Health (Code: 002868) experienced a net outflow of 6.71 million yuan from institutional investors [2]

Core Viewpoint - The investor relations event held on September 19, 2025, focused on the core businesses of Xianfeng Holdings, particularly in the fields of copper-clad laminates and animal health vaccines, attracting significant market attention [1][2]. Group 1: Copper-Clad Laminate Business - Investors showed particular interest in the performance of the copper-clad laminate business since July, focusing on aspects such as product gross margin, customer resources, cost control, and product qualification rates [3]. - The company reported a gross margin improvement in the first half of the year through customer structure optimization and product structure upgrades, achieving a production value of approximately 350 million [3]. - There was no clear indication from the company regarding the mass production of the high-speed M8 copper-clad laminate or the status of mid-to-high-end customers [3]. - The company has established a joint venture with Jiangxi Hangyu to integrate their copper-clad laminate businesses, leveraging complementary strengths for high-performance production [3]. Group 2: Animal Health Vaccine and Other Business Situations - The animal health vaccine business is currently operating normally, and the company is actively working on market expansion, internal cost control, and quality improvement to enhance operational performance [4]. - The company is monitoring the potential auction of 114.15 million shares held by the controlling shareholder and will fulfill its information disclosure obligations regarding any changes [4]. - Despite reporting a loss in the net profit excluding non-recurring items, the company aims to improve its operational situation by expanding market reach and enhancing cost efficiency across all business areas [4]. - The main business focus remains on copper-clad laminates, which are part of the new productivity electronic information industry [4].

Group 1: Business Performance - The core business of copper-clad laminates has shown improvement in gross profit margin, customer resources, cost control, and product qualification rate compared to the first half of the year, achieving a profit of over 200,000 in the first half of 2025 [2][3] - The company has implemented customer structure optimization and product structure upgrades, resulting in a certain degree of gross margin improvement in the first half of the year [3] - The company’s copper-clad laminate business generated an output value of approximately 350 million in the first half of 2025 [3] Group 2: Operational Strategies - The company is actively exploring the market and will further enhance cost control and quality improvement to boost operational efficiency [3][4] - The company is currently engaged in a joint venture with Jiangxi Hangyu to produce high-performance copper-clad laminates, leveraging complementary resources [3] - The company plans to maintain focus on its core business of copper-clad laminates and will not abandon its animal vaccine business, which is operating normally [2][3] Group 3: Investor Relations - The company assures that it will fulfill its information disclosure obligations regarding any changes in the shareholding of its controlling shareholder [3] - The company has not engaged in PCB business and is focused on its core operations [4] - The company is committed to improving its operational status through various measures, despite reporting a loss in its interim results [4]

Market Overview - On September 19, the animal health sector declined by 0.26% compared to the previous trading day, with the driving force leading the decline [1] - The Shanghai Composite Index closed at 3820.09, down 0.3%, while the Shenzhen Component Index closed at 13070.86, down 0.04% [1] Stock Performance - Notable stock movements included: - *ST Lvkang (002868): Closed at 27.56, up 4.99% with a trading volume of 38,500 shares and a turnover of 105 million yuan [1] - Kexin Biological (688526): Closed at 18.08, up 0.39% with a trading volume of 22,700 shares and a turnover of 40.94 million yuan [1] - Driving Force (838275): Closed at 10.50, down 4.11% with a trading volume of 21,200 shares and a turnover of 22.63 million yuan [2] Capital Flow - The animal health sector experienced a net outflow of 91.4 million yuan from institutional investors, while retail investors saw a net inflow of 70.15 million yuan [2] - The capital flow for individual stocks showed: - RuiPu Biological (300119): Net inflow of 16.56 million yuan from institutional investors, but a net outflow of 21.57 million yuan from retail investors [3] - *ST Lvkang (002868): Net inflow of 6.13 million yuan from institutional investors, with a net outflow of 4.21 million yuan from retail investors [3]

Market Overview - On September 18, the animal health sector declined by 0.77% compared to the previous trading day, with Huisheng Biological leading the decline [1] - The Shanghai Composite Index closed at 3831.66, down 1.15%, while the Shenzhen Component Index closed at 13075.66, down 1.06% [1] Stock Performance - The following stocks in the animal health sector showed notable performance: - *ST Lvkang (002868): Closed at 26.25, up 5.00% with a trading volume of 3433 lots [1] - Shengbi Biological (600201): Closed at 66.8, down 2.39% with a trading volume of 55.74 million [1] - Ruipu Biological (300119): Closed at 22.06, unchanged with a trading volume of 111.3 million [1] - Other stocks such as Jinhai Biological (002688) and Shunlian Biological (688098) also experienced declines of 1.98% and 2.02% respectively [1][2] Capital Flow - The animal health sector experienced a net outflow of 126 million yuan from institutional investors, while retail investors saw a net inflow of 92.38 million yuan [2] - The following stocks had significant capital flow: - Ruipu Biological: Net inflow of 12.35 million yuan from institutional investors [3] - *ST Lvkang: Net outflow of 3.83 million yuan from institutional investors [3] - Jinhai Biological: Net outflow of 25.51 million yuan from institutional investors [3]

Market Overview - On September 16, the animal health sector declined by 0.41%, with *ST Lvkang leading the drop [1] - The Shanghai Composite Index closed at 3861.87, up 0.04%, while the Shenzhen Component Index closed at 13063.97, up 0.45% [1] Stock Performance - Key stocks in the animal health sector showed mixed performance, with the following notable movements: - Xianfeng Holdings (002141) increased by 2.27% to close at 4.06 [1] - Haili Biological (603718) rose by 1.27% to 7.17 [1] - *ST Lvkang (002868) fell by 4.34% to 23.81, leading the decline [2] - The trading volume and turnover for selected stocks were significant, with Xianfeng Holdings achieving a turnover of 1.02 billion [1] Capital Flow Analysis - The animal health sector experienced a net outflow of 15.97 million from institutional investors, while retail investors saw a net inflow of 11.29 million [2][3] - Notable capital flows included: - Biological Shares (600201) had a net inflow of 12.28 million from institutional investors [3] - *ST Lvkang (002868) saw a net outflow of 2.89 million from institutional investors [3] - Retail investors contributed positively to several stocks, including a net inflow of 12.59 million into Shenyuan Biological (688098) [3]